pemetrexed 500mg powder for concentrate for solution for infusion
mcdermott laboratories ltd t/a gerard laboratories - pemetrexed disodium - pdr/conc/soln for infus - 500 milligram(s) - antimetabolites
pemetrexed
generics (uk) limited - pemetrexed disodium - pdr/conc/soln for infus - 500 milligram - antimetabolites
pemetrexed-rz pemetrexed (as disodium) 100 mg powder for injection vial
dr reddys laboratories australia pty ltd - pemetrexed disodium, quantity: 110.28 mg (equivalent: pemetrexed, qty 100 mg) - injection, powder for - excipient ingredients: mannitol - malignant pleural mesothelioma,in combination with cisplatin, is indicated for the treatment of patients with malignant pleural mesothelioma.,non small cell lung cancer,in combination with cisplatin, is indicated for initial treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.,as monotherapy, is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology after prior platinum based chemotherapy.
pemetrexed powder for solution
apotex inc - pemetrexed (pemetrexed disodium) - powder for solution - 500mg - pemetrexed (pemetrexed disodium) 500mg - antineoplastic agents
pemetrexed powder for solution
apotex inc - pemetrexed (pemetrexed disodium) - powder for solution - 100mg - pemetrexed (pemetrexed disodium) 100mg - antineoplastic agents
pemetrexed 100mg powder for concentrate for solution for infusion vials
seacross pharmaceuticals ltd - pemetrexed disodium - powder for solution for infusion - 100mg
pemetrexed 500mg powder for concentrate for solution for infusion vials
seacross pharmaceuticals ltd - pemetrexed disodium - powder for solution for infusion - 500mg
alimetrex pemetrexed (as disodium) 500 mg powder for injection vial
medtas pty ltd - pemetrexed disodium, quantity: 551.5 mg - injection, powder for - excipient ingredients: mannitol - malignant pleural mesothelioma. pemetrexed, in combination with cisplatin, is indicated for the treatment of patients with malignant pleural mesothelioma.,non-small cell lung cancer. pemetrexed in combination with cisplatin is indicated for initial treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed as monotherapy is indicated for the treatment of patients with locally advanced or metastatic non-small-cell lung cancer other than predominantly squamous cell histology after prior platinum-based chemotherapy.
alimetrex pemetrexed (as disodium) 100 mg powder for injection vial
medtas pty ltd - pemetrexed disodium, quantity: 110.3 mg - injection, powder for - excipient ingredients: mannitol - malignant pleural mesothelioma. pemetrexed, in combination with cisplatin, is indicated for the treatment of patients with malignant pleural mesothelioma.,non-small cell lung cancer. pemetrexed in combination with cisplatin is indicated for initial treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed as monotherapy is indicated for the treatment of patients with locally advanced or metastatic non-small-cell lung cancer other than predominantly squamous cell histology after prior platinum-based chemotherapy.
pemetrexed for injection, usp powder for solution
dr reddy's laboratories ltd - pemetrexed (pemetrexed disodium) - powder for solution - 100mg - pemetrexed (pemetrexed disodium) 100mg - antineoplastic agents